USANA Health Sciences, Inc. (NYSE:USNA) Insider Sells $178,707.74 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Daniel A. Macuga sold 3,791 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

USANA Health Sciences Trading Down 3.3 %

USANA Health Sciences stock opened at $45.55 on Friday. The firm has a 50-day moving average of $46.62 and a 200-day moving average of $48.30. The firm has a market cap of $876.38 million, a P/E ratio of 14.19, a P/E/G ratio of 1.38 and a beta of 0.94. USANA Health Sciences, Inc. has a 1-year low of $41.45 and a 1-year high of $69.60.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.35. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. The company had revenue of $221.08 million during the quarter, compared to analyst estimates of $206.70 million. Research analysts forecast that USANA Health Sciences, Inc. will post 2.75 earnings per share for the current fiscal year.

Institutional Trading of USANA Health Sciences

Institutional investors and hedge funds have recently bought and sold shares of the stock. Quest Partners LLC purchased a new stake in USANA Health Sciences in the fourth quarter worth about $66,000. CWM LLC lifted its holdings in USANA Health Sciences by 49.6% in the fourth quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after buying an additional 420 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in USANA Health Sciences by 60.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock worth $198,000 after buying an additional 1,274 shares during the period. Trexquant Investment LP purchased a new stake in USANA Health Sciences in the fourth quarter worth about $266,000. Finally, Teacher Retirement System of Texas purchased a new position in shares of USANA Health Sciences during the third quarter valued at approximately $297,000. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Friday, January 12th. DA Davidson dropped their target price on shares of USANA Health Sciences from $53.00 to $48.00 and set a “neutral” rating for the company in a report on Thursday, February 22nd.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.